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Circadian rhythms govern a large array of metabolic
and physiological functions. The central clock
protein CLOCK has HAT properties. It directs acety-
lation of histone H3 and of its dimerization partner
BMAL1 at Lys537, an event essential for circadian
function. We show that the HDAC activity of the
NAD+-dependent SIRT1 enzyme is regulated in a cir-
cadian manner, correlating with rhythmic acetylation
of BMAL1 and H3 Lys9/Lys14 at circadian pro-
moters. SIRT1 associates with CLOCK and is
recruited to the CLOCK:BMAL1 chromatin complex
at circadian promoters. Genetic ablation of the Sirt1
gene or pharmacological inhibition of SIRT1 activity
lead to disturbances in the circadian cycle and in
the acetylation of H3 and BMAL1. Finally, using
liver-specific SIRT1 mutant mice we show that
SIRT1 contributes to circadian control in vivo. We
propose that SIRT1 functions as an enzymatic rheo-
stat of circadian function, transducing signals origi-
nated by cellular metabolites to the circadian clock.
INTRODUCTION
The epigenetic basis of many developmental, physiological,
and metabolic processes is manifest. Epigenetic mechanisms
control gene expression by potentially reversible changes in
DNA methylation and chromatin structure. The remodeling of
chromatin is largely elicited by enzyme-catalyzed posttransla-
tional modifications of the core histone N-terminal tails (Kouzar-
ides, 2007; Li et al., 2007a; Peterson and Laniel, 2004; Strahl
and Allis, 2000). These include acetylation, poly(ADP-ribosyla-
tion), ubiquitination, methylation, and phosphorylation and rep-
resent critical regulatory events of a large array of nuclear re-
sponses. Unique combinations of these modifications, for
which the ‘‘histone code’’ hypothesis has been formulated
(Strahl and Allis, 2000), induce conformational changes of chro-
matin, rendering it permissive to transcription, silencing, DNAreplication, and repair (Cheung et al., 2000a; Kouzarides,
2007; Kurdistani and Grunstein, 2003; Li et al., 2007a; Strahl
and Allis, 2000).
Histone acetylation is recognized as one of the most promi-
nent epigenetic marks leading to activation of gene expression
(Strahl and Allis, 2000). Acetylation of the 3-amino groups of spe-
cific lysine residues in the N termini of core histones is generally
associated with transcription activity, as it is thought to induce
an open chromatin conformation that allows the transcription
machinery access to promoters (Cheung et al., 2000a; Li et al.,
2007a; Struhl, 1998). Indeed, acetylation of lysines in histones
neutralizes the positive electric charge between the negatively
charged DNA backbone and tips the balance toward relaxing
chromatin. Deacetylation, on the other hand, would shift the bal-
ance back to condensing chromatin and silencing gene expres-
sion. The enzymes that elicit these critical transitions are histone
acetyltransferases (HAT) and histone deacetylases (HDAC).
HDAC-mediated deacetylation of histones correlates with gene
silencing (Grunstein, 1997; Struhl, 1998; Wade and Wolffe, 1997;
Workman and Kingston, 1998). HDACs have also been impli-
cated in the reversible acetylation of nonhistone proteins, includ-
ing p53 (Luo et al., 2001; Vaziri et al., 2001), Hsp90 (Kovacs et al.,
2005), MyoD (Mal et al., 2001), and E2F1 (Martinez-Balbas et al.,
2000). Mammalian HDACs have been classified into four classes
based on their structure and regulation (Yang and Seto, 2008).
There are seven mammalian enzymes constituting class III; these
are homologs of yeast Sir2 (silencing information regulator) and
are known as SIRT1 to SIRT7. These proteins are structurally dis-
tinct from the other HDACs and have the property of dynamically
sensing cellular energy metabolism (Bordone and Guarente,
2005). Indeed, unlike other HDACs, SIRT proteins catalyze a
unique reaction that requires the coenzyme NAD+ (nicotinamide
adenine dinucleotide). In this reaction, nicotinamide (NAM) is liber-
ated from NAD+ and the acetyl group of the substrate is trans-
ferred to cleaved NAD+, generating the metabolite O-acetyl-ADP
ribose (Sauve et al., 2006). Due to the NAD+ dependency, SIRTs
are thought to constitute one of the functional links between
metabolic activity and genome stability and, finally, aging (Bishop
and Guarente, 2007).
In yeast, the Sir2 complexmediates transcriptional silencing at
telomeres and regulates the pace of aging (Chopra and Mishra,Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc. 329
2005; Oberdoerffer and Sinclair, 2007). Because of the NAD+ re-
quirement for Sir2 deacetylase activity, it is evident that silencing
is likely coupled to themetabolic cycle of cells. InC. elegans, one
of the Sir2 orthologs, Sir2.1, has been shown to prevent aging
(Tissenbaum and Guarente, 2001).
SIRT1, the mammalian ortholog of Sir2, is a nuclear protein
that occupies a privileged position in the cell and governs critical
metabolic and physiological processes. SIRT1 helps cells to be
more resistant to oxidative or radiation-induced stress (Brunet
et al., 2004; Luo et al., 2001), promotes mobilization of fat from
white adipose tissues, an event that contributes to extending
the life span (Picard et al., 2004), and mediates the metabolism
of energy sources in metabolically active tissues (Lagouge
et al., 2006; Rodgers et al., 2005). At the level of chromatin,
SIRT1 enzymatic activity preferentially targets histone H3 at
Lys9 and Lys14 and histone H4 at Lys16 (Imai et al., 2000). In ad-
dition, a number of nonhistone proteins, including p53 (Luo et al.,
2001; Vaziri et al., 2001), FOXO3 (Brunet et al., 2004; Motta et al.,
2004), PGC-1a (Nemoto et al., 2005; Rodgers et al., 2005), and
LXR (Li et al., 2007a), are regulated by SIRT1-mediated deacety-
lation, stressing the pivotal function that this regulator plays in
cellular control and responses.
A remarkable array of metabolic and physiological processes
display daily oscillations (Panda et al., 2002; Storch et al., 2002;
Ueda et al., 2002), and an intimate interplay exists between
circadian clocks and metabolic rhythms in all organisms (Wijnen
and Young, 2006). The discovery that a core element of the
circadian clock machinery, the protein CLOCK, is an enzyme
with HAT activity (Doi et al., 2006) revealed the crucial role that
chromatin remodeling plays in the circadian regulation of gene
expression (Hardin and Yu, 2006; Nakahata et al., 2007).
More recently, the finding that CLOCK specifically also acety-
lates nonhistone targets, such as its own partner BMAL1, sug-
gested that it may control a number of physiological cellular
functions (Hirayama et al., 2007). The intrinsic nature of SIRT1
as a NAD+-dependent HDAC prompted us to explore the possi-
bility that SIRT1 could participate in circadian control by regulat-
ing the HAT function of CLOCK. This would uncover a unique
example of control of gene expression bymetabolites (Ladurner,
2006).
Here we report that the HDAC activity of SIRT1 is regulated in
a circadian manner in cultured cells and in the liver. SIRT1 phys-
ically associates with CLOCK and contributes to the acetylated
state of CLOCK targets, such as Lys9/Lys14 in the tail of histone
H3 and Lys537 in the BMAL1 protein. CLOCK, BMAL1, and
SIRT1 colocalize in a chromatin-associated regulatory complex
at promoters of clock-controlled genes. Pharmacological inhibi-
tion of SIRT1 activity by NAM and the drug splitomicin causes
a loss in stringency of circadian gene expression, an effect
equally observed in mouse embryo fibroblasts (MEFs) derived
from Sirt1 null mice. Importantly, this effect is paralleled by a sig-
nificant reduction in the oscillation of H3 and BMAL1 acetylation.
Finally, using tissue-specificmutantmice, in which theSirt1 gene
is mutated uniquely in the liver, we demonstrate that SIRT1 con-
tributes to circadian regulation in vivo. We propose that SIRT1
functions as an enzymatic rheostat of CLOCK function, thereby
transducing signals originated by cellular metabolites to the
circadian machinery.330 Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc.RESULTS
SIRT1 Deacetylase Activity Is Circadian
The CLOCK protein is one of the few core circadian regulators
whose levels do not oscillate in most settings (Lee et al., 2001).
Thus, we predicted that its HAT activity would oscillate in a circa-
dian manner, thereby explaining the physiological remodeling of
chromatin (Doi et al., 2006). An alternative scenario implicates
a regulated HDAC, whose activity may function as rheostat of
the HAT’s function of CLOCK.
To assesswhether SIRT1may be regulated in a circadianman-
nerwepreparedRNAandproteinextracts fromserum-stimulated
cultured MEFs and from mouse liver at various Zeitgeber times
(ZT). In both cases, the transcript and protein levels of SIRT1 re-
mained constant, as determined using two anti-SIRT1-specific
antibodies (Figure 1A; see also later, Figure 7B) and reverse tran-
scription (RT)-PCR (Figures 1B and 1C, where dbp is shown as
a control from the same RNA preparations). We have also deter-
mined the levels of SIRT1 in nuclear fractions prepared in various
manners. Again SIRT1 protein levels showed either modest or no
oscillation (Figure S1 available online). Thus, we turned to deter-
mining whether SIRT1 deacetylase activity may oscillate.
We found that the endogenous liver SIRT1 obtained by immu-
noprecipitation from entrained mice, although constant in levels,
displays circadian HDAC activity that peaks at ZT15 (Figure 1D),
a time that remarkably parallels the minimal transcriptional levels
of various clock-controlled genes in the liver (such as dbp,
Figure 1C).
To confirm that equal levels of SIRT1 could still generate circa-
dian HDAC function, we complemented cellular extracts with
equal amounts of recombinant SIRT1 protein and acetylated
p53 peptide as SIRT1 substrate (Luo et al., 2001; Vaziri et al.,
2001). This assay likely reflects the intracellular relative concen-
trations of NAD+ and NAM, or of yet undefined circadian metab-
olites, whose ratio determines SIRT1 activity (Imai et al., 2000;
Luo et al., 2001). Extracts from wild-type (WT) MEFs were pre-
pared every 6 hr post-serum shock (Figure 1E), and liver extracts
were prepared at four different ZT from entrained mice (Fig-
ure 1F). Also, under these conditions we found that SIRT1 deace-
tylase activity is rhythmic, peaking 24 hr post-serum shock in
MEFs (Figure 1E) and at ZT15 in the liver (Figure 1F). Importantly,
the peak of SIRT1 deacetylase activity is consistent with the cy-
clic acetylation of histone H3 at promoters of clock-controlled
genes; at 24 hr, this acetylation is at its lowest levels (see later,
Figure 4).
SIRT1 Contributes to the Stringency
of Circadian Gene Expression
The finding that SIRT1 activity is regulated in a circadian manner
prompted us to investigate its role in clock gene expression and
chromatin remodeling. MEFs generated from WT and Sirt1 null
mice were serum-shocked, RNA was prepared at various times,
and quantitative RNase protection assay was used to monitor
dbp circadian gene transcription (Figure 2A). The analysis
reveals that genetic ablation of SIRT1 causes changes in circa-
dian gene expression, including an overall increase in the tran-
scription levels and a broadening of the oscillation cycles, with
earlier onsets of increasing transcription and later decreases.
Figure 1. SIRT1 Deacetylase Activity Is Circadian in Serum-Shocked MEFs and in the Liver
(A) Endogenous SIRT1 and BMAL1 expression in MEFs after serum shock were determined by western blot.
(B and C) Sirt1 (B) and Dbp (C) genes expression in liver was analyzed by quantitative PCR. The highest expression time point was set to 1.
(D) Endogenous SIRT1 proteins from livers of entrained mice at indicated time points were immunoprecipitated and subjected to deacetylation assays. The value
at ZT15 was set to 1. Top panel shows the amount of immunoprecipitated SIRT1.
(E) Cell extracts prepared from serum-shocked MEFs at indicated time points were complemented with recombinant SIRT1 protein and acetylated p53 peptide
as substrate and subjected to deacetylation assay. Value at time 0 was set to 1.
(F) Liver extracts prepared from entrained mice were complemented with recombinant SIRT1 protein and acetylated p53 peptide as substrate and subjected
to deacetylation assay. Values at ZT15 were set to 1. All data presented are the means ± standard errors of the mean (SEM) of three independent samples.Importantly, the expression of a nonoscillating gene (clock) is not
affected (Figure 2A). These observations are consistent with
SIRT1 having a role in controlling the stringency of circadian
gene expression and being involved in the oscillatory silencing
that periodically follows a transcriptional peak. These results
were confirmed by quantitative RT-PCR and reproduced also
on the Per2 gene (Figure 2B). Finally, a point-by-point circadian
analysis of the differential transcription of both dbp and per2 be-
tween WT and Sirt1/ MEFs confirms that the lack of Sirt1 in-
duces a significantly higher transcriptional efficacy at specific
times that normally precede and follow each circadian expres-
sion peak (Figure 2C).
The effect of Sirt1 genetic ablation on circadian gene expres-
sion was confirmed with pharmacological treatments using
SIRT1 inhibitors (splitomicin and NAM) (Figure 3A), which had
no effect on the Sirt1/ MEFs (not shown). Analysis of dbp ex-
pression levels in WT MEFs treated with either inhibitors re-
vealed a pattern highly similar to the one obtained with the
Sirt1 null cells, basically displaying a significantly broader
phase and higher amplitude in the oscillation (Figure 3A).SIRT1 Controls Circadian Histone Acetylation
The finding that CLOCK is a HAT revealed that chromatin remod-
eling is intimately connected to circadian physiology (Doi et al.,
2006; Grimaldi et al., 2007). The remarkable effect of SIRT1
on clock gene expression (Figures 2 and 3) suggested that this
effect may be mediated by changes in histone acetylation at
specific sites. We analyzed the acetylation at Lys9 and Lys14
of histone H3 because we had previously found these to be
preferential sites of CLOCK’s HAT activity (Doi et al., 2006),
and also because SIRT1 deacetylase function was described
to be targeted to these lysines (Imai et al., 2000). We performed
chromatin immunoprecipitation (ChIP) assays using WT MEFs
stimulated by a serum shock. Acetylation of H3 at the Dbp
transcription start site (TSS) follows a circadian profile (Figure 3B
and Ripperger and Schibler, 2006), presumably due to the
concerted action of CLOCK and of an HDAC. Pharmacological
treatment with the SIRT1 inhibitors (splitomicin and NAM) in-
duced a loss in the circadian oscillation of acetylation, ge-
nerating a noncyclic, high level of Lys9/Lys14 acetylation
(Figures 3C and 3D).Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc. 331
Figure 2. SIRT1 Regulates Circadian mRNA Expression of dbp and per2 Genes
(A) dbp and clock mRNA expression levels in wild-type (WT) and Sirt1 null (Sirt1/) MEFs after serum shock were examined by RNase protection assay.
Representative results are shown and experiments were done using four independent samples.
(B) dbp and per2mRNA expression profiles inWT andSirt1/MEFs after serum shockwere analyzed by quantitative PCR. Time 0 value inWTMEF for each gene
was set to 1. All data presented are the means ± SEM of three independent samples.
(C) Relative increment/decrement of dbp and per2 gene expression. Plus values on vertical lines mean increment and minus values on vertical lines indicate
decrement.Next, we extended this analysis to the MEFs from the Sirt1/
mice. Again, histoneH3displays a robust cyclic acetylation at the
Dbp promoter in WTMEFs, while genetic ablation of Sirt1 results
in a constitutive, high acetylation at Lys9/Lys14 (Figures 4A and
4B). Thus, SIRT1 plays a critical role in maintaining a controlled
rhythmicity in histone acetylation, thereby contributing to circa-
dian chromatin remodeling.
SIRT1 Is in a Chromatin Complex with CLOCK:BMAL1
on the Dbp Promoter
Based on the pattern of histone acetylation associated with cir-
cadian genes (Figures 3 and 4A), it is conceivable that CLOCK
and SIRT1 converge in a coordinate manner to the same regula-
tory regions. Thus, we decided to test whether SIRT1 is recruited
to E-box elements present in the regulatory region of CLOCK:
BMAL1-controlled genes. To do so, we performed a dual cross-
linking ChIP assay and analyzed two E-box elements within the
Dbp gene. As predicted (Ripperger and Schibler, 2006), CLOCK
and BMAL1 are recruited to E-box elements in the Dbp gene in
a time-dependent manner (Figure 4D). Importantly, we found
that SIRT1 is jointly recruited to the same E-box elements in
the Dbp gene. Furthermore, the presence of SIRT1 is temporally332 Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc.regulated and parallels the recruitment of the CLOCK:BMAL1
dimer (Figures 4D and 4E). Since SIRT1 is not a DNA-binding
protein, we favor a scenario in which SIRT1 recruiting to a circa-
dian promoter is mediated by the CLOCK:BMAL1 dimer. These
results indicate that CLOCK:BMAL1 and SIRT1 coexist in a chro-
matin regulatory complex that operates on circadian promoters.
Direct Interaction of SIRT1 and CLOCK
The coordinated recruiting of the CLOCK:BMAL1 dimer
and SIRT1 to circadian gene promoters suggested that these
regulators may physically interact. To test this possibility we
coexpressed SIRT1 with CLOCK in cultured cells. In coimmuno-
precipitation experiments we reveal that SIRT1 interacts with
CLOCK but not with PER2 (Figure 5A). Next, we wished to estab-
lish whether native, endogenous cellular SIRT1 interacts with
CLOCK. Native SIRT1 can be coimmunoprecipitated with both
CLOCK and BMAL1 in liver extracts, indicating that it interacts
with the CLOCK:BMAL1 complex (Figure 5B). It is unclear why
BMAL1 in transfected cells does not seem to coimmunoprecipi-
tate with the SIRT1-CLOCK complex (Figure 5A), but the results
on native proteins (Figure 5B) suggest the requirement of some
specific physiological conditions.
Figure 3. Circadian Histone H3 (Lys9/Lys14) Acetylation at dbp TSS Is Dependent on SIRT1 Activity
(A)Dbp expression levels in MEFs either treated with SIRT1 inhibitors (10 mMNAM or 120 mM splitomicin) or not were analyzed by quantitative PCR. The value at
time 20 in MEFs without treatment was set to 1.
(B–D) Crosslinked cell extracts were isolated fromMEF without treatment (B) or with SIRT1 inhibitors, 10 mMNAM (C), or 120 mM splitomicin (D) at indicated time
points after serum shock, subjected to ChIP assay, and analyzed by quantitative PCRwith dbp TSS primers (See Figure 4C). Results of semiquantitative PCR are
also shown at the bottom of each experiment. The value at time 16 in MEFs without treatment was set to 1. All data presented are the means ± SEM of three
independent samples.We also followed the SIRT1-CLOCK interaction during the
circadian cycle (Figure 5C). To do so, we coimmunoprecipitated
SIRT1 from MEFs by using anti-CLOCK-specific antibody at
various times after serum shock. While it would appear that the
association undergoes some mild variations, after quantification
of three different experiments we concluded that the SIRT1-
CLOCK interaction is mostly stable during the circadian cycle
(Figure 5C). We have also found that the CLOCK-SIRT1 interac-
tion is not significantly modulated by agents known or likely to
influence SIRT1 function, including NAD+, pyruvate, resveratrol,
splitomicin, desferroxamine, and glucose (Figure S2).
Finally, theCLOCK-SIRT1 interaction doesnot appear to require
the HDAC function. We used a SIRT1 mutant with a single amino
acid substitution that diminishes the deacetylase activity (SIRT1-
(H363Y); Vaziri et al., 2001). The mutated protein interacts with
CLOCKwithefficacyequivalent to thatofnormalSIRT1 (Figure5D).
To identify the protein regions involved in SIRT1-CLOCK asso-
ciation, we performed GST pulldown assays (Figures 5E and 5F).
We found that the central region of CLOCK (aa 450–570) is
necessary for interaction with SIRT1. Interestingly, this region
contains the serine/threonine-rich domain, which we predicted
to be involved in regulated protein interactions (Doi et al.,2006), and exon 19, the domain originally found to be essential
for CLOCK function (Antoch et al., 1997). In SIRT1, the N-termi-
nal region (aa 1–231) is necessary and sufficient for eliciting
efficient interaction with CLOCK (Figure 5F). This information is
of interest because the same SIRT1 domain is involved in the
interaction with other regulatory proteins. Specifically, it has
been recently found to mediate the interaction with the histone
methyltransferase SUV39H1 (Vaquero et al., 2007), a regulatory
event that results in increased levels of the H3K9me3 modifica-
tion and thereby control of heterochromatin formation.
BMAL1 Acetylation at Lys537 Is Regulated by SIRT1
Recently we have reported that BMAL1 is rhythmically acety-
lated by CLOCK and that this event is essential for control of
circadian function (Hirayama et al., 2007). We have generated
an antibody that specifically recognizes acetylated BMAL1 at
Lys537 (Figure S3). Because of the interplay between CLOCK
and SIRT1, we suspected that the deacetylase that could regu-
late the dynamic levels of BMAL1 acetylation could be SIRT1.
To identify which class of HDAC is responsible for deacetylation
of BMAL1, we treated cultured cells expressing Myc-CLOCK
and Flag-Myc-BMAL1 with class I and II inhibitor, trichostatin ACell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc. 333
Figure 4. SIRT1 Is Recruited to the E-box and Regulates Circadian Histone Acetylation on the Dbp Gene
(A and B) Histone H3 (Lys9/Lys14) acetylation atDbp TSS is hyperacetylated in SIRT1-deficient MEFs. Crosslinked cell extracts were isolated fromWT or SIRT1-
deficient MEFs at indicated time points after serum shock, subjected to ChIP assay with anti-acetyl histone H3 (Lys9/Lys14) and control IgG, and analyzed by
semiquantitative PCR (A) or quantitative PCR (B) with TSS primers. Control IgG was used as a control for immunoprecipitation. The value at time 16 in WT MEF
was set to 1.
(C) Schematic diagram of the mouse Dbp promoter and primers used for ChIP assay.
(D) Representative results of the ChIP assay analyzed by semiquantitative RT-PCR. Dual crosslinked cell extracts were isolated fromMEF after 16 or 24 hr serum
shock and subjected to ChIP assay with anti-SIRT1, anti-CLOCK, anti-BMAL1, or no antibody (ctrl). No antibody and 30R primers were used as controls for
immunoprecipitation and PCR, respectively.
(E) Quantification of ChIP by quantitative PCR. Quantitative PCR was performed on the same samples as described in (D). All data presented are the means ±
SEM of three independent samples.(TSA), and/or class III inhibitor, NAM, for 6 hr and 16 hr, respec-
tively. Acetylation of BMAL1 at Lys537 is significantly increased
by NAM treatment but not by TSA treatment (Figure 6A).
We then coexpressed BMAL1with CLOCK and confirmed that
the anti-AcBMAL1 antibody readily recognizes CLOCK-induced
acetylation at Lys537 (Figure 6B). In the same assay, coexpres-
sion of SIRT1, but not SIRT2 and SIRT3, induced specific deace-
tylation of BMAL1 (Figure 6B), indicating that SIRT1 specifically
deacetylates BMAL1. We also confirmed that SIRT1 readily de-
acetylates BMAL1 in an in vitro deacetylation assay (Figure S4).
Importantly, the SIRT1(H363Y) enzymatically deficient mutant
did not affect the acetylation state of BMAL1 (Figure 6C).
Furthermore, BMAL1 deacetylation by SIRT1 is responsive to
NAD+ and significantly attenuated by NAM (Figure 6D), suggest-
ing that the acetylation of BMAL1 is an event regulated by cellular
metabolism.
SIRT1 Contributes to Circadian Control In Vivo
To determine the effect of SIRT1 on the cyclic acetylation of
BMAL1 we first compared MEFs from WT mice and Sirt1/334 Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc.animals. Upon serum shock, acetylation at Lys537 is cyclic in
WT cells, whereas it is sustained and mostly constant in Sirt1/
MEFs (Figure 7A). Interestingly, lack of acetylation appears to
also influence BMAL1 phosphorylation levels (Figure 7A). As
phosphorylation has been linked to BMAL1 stability (Cardone
et al., 2005; Kondratov et al., 2003), it is interesting to observe
that BMAL1 appears indeed to be expressed at higher levels in
the absence of SIRT1. These results suggest that SIRT1-
controlled acetylation could constitute a critical regulatory step
in the control of BMAL1 protein stability.
Next we sought to demonstrate the role of SIRT1 in vivo. To do
so, we used tissue-specificSirt1/mice inwhich the loxed gene
was selectively deleted by albumin promoter-driven Cre recom-
binase in the liver. The original mutant mice have the unique
deletion of exon 4 of the Sirt1 gene, which encodes the con-
served SIRT1 catalytic domain (Cheng et al., 2003). Livers
were collected from mice entrained at different times of the cir-
cadian cycle and used to analyze BMAL1 acetylation and gene
expression levels. Paralleling the results obtained with the
Sirt1/ MEFs (Figure 7A), BMAL1 acetylation is significantly
Figure 5. Interaction of SIRT1 with CLOCK
(A) JEG3 cells were cotransfected with a series of expression vectors as described. Flag-tagged SIRT1 proteins were immunoprecipitated by FLAG antibody, and
abundance of coimmunoprecipitated proteins was determined by western blotting using anti-Myc antibody (top right panel) and anti-SIRT1 antibody (bottom
right panel). Left panels show the immunoblotting results of total cell lysates as an input.
(B and C) SIRT1 and CLOCK interaction in vivo. Endogenous CLOCK:BMAL1 and SIRT1 interactions in the mice liver (B) and in cultured MEFs after serum shock
(C) were determined by coimmunoprecipitation assays.
(D) The deacetylase-deficient (H363Y) mutant SIRT1 interacts with CLOCK as well as WT SIRT1.
(E) CLOCK (aa 450–570) is required for the interaction with SIRT1. In vitro-translated [35S]-labeled truncated CLOCK proteins were pulled down by GST-SIRT1.
(F) SIRT1 N terminus (aa 1–231) is required for CLOCK interaction. In vitro-translated [35S]-labeled full-length CLOCK proteins were pulled down by truncated
GST-SIRT1.increased and only mildly rhythmic in the livers from the mutant
mice (Figure 7B). BMAL1 phosphorylation is also slightly
increased with respect to WT mice, although not to the extent
observed in the Sirt1/ MEFs (see also Figure S5). Finally, ex-
pression of the circadian genes Cry1 and Per2 is also signifi-
cantly altered (Figure 7C), reminiscent of the results obtained
with the Sirt1/ MEFs (Figure 2).
DISCUSSION
A large array of metabolic processes follows the rhythmicity of
the circadian cycle. The presence of molecular links that reveal
functional wiring between the clock machinery and metabolic
pathways has been invoked (Rutter et al., 2002; Schibler and
Sassone-Corsi, 2002), and much compelling evidence has ac-
cumulated (Turek et al., 2005; Wijnen and Young, 2006). Wehave proposed that the HAT function of CLOCK may be con-
trolled by changing cell energy levels or, conversely, could reg-
ulate them (Doi et al., 2006; Grimaldi et al., 2007). The finding
that a core element of the clock machinery directly elicits
histone modifications underscored the link between cir-
cadian physiology and chromatin remodeling. These notions
suggested that NAD(H)-dependent energy pathways in the
cell could influence the HAT function of CLOCK:BMAL1. We
reasoned that CLOCK-mediated acetylation, and thereby tran-
scriptional activation, could be counterbalanced by transcrip-
tional silencing induced by NAD+-dependent HDACs (Imai
et al., 2000; Landry et al., 2000). Intriguingly Sir2, a NAD+-de-
pendent HDAC, had been functionally linked to Sas2 (Kimura
et al., 2002; Suka et al., 2002), a protein of the MYST family
of HATs to which CLOCK belongs (Doi et al., 2006; Nakahata
et al., 2007).Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc. 335
Figure 6. SIRT1 Regulates BMAL1 Lys537 Acetylation
(A) Class III HDAC inhibitor enhances BMAL1 Lys537 acetylation. JEG3 cells transfected withMyc-CLOCK and Flag-Myc-BMAL1were treated with HDAC I and II
inhibitor, TSA (1 mM), for 6 hr and HDAC III inhibitor, NAM (10 mM), for 16 hr before harvest. Immunoprecipitated BMAL1 proteins by FLAG antibody were
subjected to SDS-PAGE and probed with acetylated BMAL1 or Myc antibodies.
(B) SIRT1 deacetylates acetylated Lys537 in BMAL1. JEG3 cells transfected with Myc-CLOCK and Flag-Myc-BMAL1 were cotransfected with SIRT1-Flag,
SIRT2-Flag, or SIRT3-Flag. Immunoprecipitated BMAL1 proteins by FLAG antibody were probed with acetylated BMAL1 or Myc antibodies. Immunoprecipitated
SIRT proteins by FLAG antibody were probed with FLAG M2 antibody.
(C) Acetylated BMAL1 is not deacetylated by deacetylase-deficient mutant SIRT1. JEG3 cells transfected withMyc-CLOCK and Flag-Myc-BMAL1were cotrans-
fected with WT or mutant (H363Y) SIRT1-HA. Immunoprecipitated BMAL1 proteins by FLAG antibody were probed with acetylated BMAL1 or Myc antibodies.
SIRT1 protein amount was detected by SIRT1 antibody.
(D) Deacetylation of BMAL1 by SIRT1 is NAD+ dependent manner. JEG3 cells transfected with Myc-CLOCK and Flag-Myc-BMAL1 and SIRT1-HA were treated
with 1 mMNAD+ or 10 mMNAM for 16 hr before harvest. Immunoprecipitated BMAL1 proteins by FLAG antibody were probed with acetylated BMAL1 antibody.
SIRT1 protein amount was detected by SIRT1 antibody.Our results indicate that SIRT1 could function as a molecular
rheostat of CLOCK-mediated HAT function, by modulating the
timing of histone lysine acetylation (Figure 7D). SIRT1 also mod-
ulates the circadian machinery by controlling the acetylation
levels of BMAL1 (Figure 6), a core circadian element whose
CLOCK-inducedacetylation is important for circadianphysiology
(Hirayama et al., 2007). BMAL1 is acetylated at a key, conserved
lysine at position Lys537.Wehave shown that Lys537 acetylation
increases the efficacy of the repressor CRY to silence CLOCK:
BMAL1-mediated transcription, an event essential to obtaining
proper circadian oscillations (Hirayama et al., 2007). Importantly,
the oscillatory acetylation patterns ofH3 andBMAL1differ in their
timing: BMAL1 acetylation is sustained at a circadian time when
H3 acetylation is at minimal levels (at 24 hr post-serum shock;
compare Figures 4A and 7A). This difference nicely fits the336 Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc.scenario of a dual role for CLOCK-mediated acetylation, impli-
cated both in transcriptional activation of circadian promoters
(acetylation of H3; Doi et al., 2006) and in their subsequent down-
regulation following acetylation of BMAL1- and CRY-mediated
repression (Hirayama et al., 2007). These findings raise the fasci-
natingpossibility thatCLOCKandSIRT1enzymatic activitiesmay
be temporally regulated by additional posttranslational modifica-
tions. Interestingly, H3 Lys14 acetylation was shown to be signif-
icantly modulated by the phosphorylation of the nearby Ser10
residue (Cheung et al., 2000b; Lo et al., 2000). Of relevance to
circadian control, phosphorylation at Ser10 has been linked to
light-induced activation of clock gene expression in the supra-
chiasmatic nucleus (SCN) (Crosio et al., 2000).
Another important question relates to whether SIRT1 would
operate on other nonhistone circadian targets. CLOCK was
Figure 7. Circadian Dysfunction and BMAL1 Upregulated Acetylation in Liver-Specific SIRT1-Deficient Mice
(A) BMAL1 Lys537 acetylation profile in WT or SIRT1-deficient MEFs was investigated. Cell extracts prepared from indicated time points were immunoprecip-
itated with BMAL1 antibody and acetylation of BMAL1 was detected by probing with the acetylated BMAL1 antibody.
(B) BMAL1 Lys537 acetylation profile inWT andSIRT1Dex4micewas investigated. Liver extracts prepared from indicated time points were immunoprecipitated by
BMAL1 antibody and acetylation of BMAL1 was detected by using the acetylated BMAL1 antibody. Acetylation of BMAL1 in the SIRT1-Dex4mutant mice is non-
rhythmic and elevated compared to WT mice. Overall levels of BMAL1 are also higher in the SIRT1-Dex4 mutant mice. The pattern of BMAL1 phosphorylation is
also altered (see also Figure S5). The lower SIRT1 band corresponds to the SIRT1-Dex4 deletion. Levels of the CLOCK protein and actin were used as control.
(C) Altered circadian expression of Cry1 and Per2 clock genes in the livers of SIRT1Dex4 mice. Error bars represent SEM.
(D) Scheme of the NAD+-dependent regulation exerted by SIRT1 on the circadian clock machinery. SIRT1 interacts with CLOCK and thereby establishes a
functional and molecular link between energy metabolism and circadian physiology.found to interact with some nuclear receptors, including RARa
and RXRa (McNamara et al., 2001). Since periodic availability
of nuclear hormones has been implicated in the resetting of
peripheral clocks (McNamara et al., 2001; Yin et al., 2007), and
since SIRT1 has been found to control a number of nuclear
receptors (see for example Li et al., 2007b), it is reasonable to
speculate that the CLOCK-SIRT1 interaction described in this
study represents a key event in the processes of fat and energy
metabolism. In this respect, it is worth noting that PGC-1, a tran-
scriptional coactivator that regulates energy metabolism
and that acts in combination with SIRT1 (Nemoto et al., 2005;
Rodgers et al., 2005), is rhythmically expressed in the liver and
skeletal muscle and is required for cell-autonomous clock func-
tion (Liu et al., 2007; Sonoda et al., 2007). Thus, the CLOCK-
SIRT1 interplay seems to occupy a privileged position in the
control of gene expression by metabolites.
CLOCK and SIRT1 appear to be associated at all times of the
circadian cycle (Figure 5), suggesting that they would not only
coordinately contribute to the dynamic oscillation of histone
acetylation but also regulate a number of nonhistonic targets.The identification of additional molecular elements within the
CLOCK:BMAL1/SIRT1 complex will define its functional
features, leading to the unraveling of intracellular regulatory
pathways yet poorly understood. In this respect, a fascinating
connection is apparent between circadian metabolism, aging,
and cancer. DNA damage accumulates with age and defects
in DNA repair may lead to phenotypes reminiscent of premature
aging (Lombard et al., 2005; Saunders and Verdin, 2007).
The conceptual and functional link existing between the circa-
dian clock and the cell cycle (Hunt and Sassone-Corsi, 2007;
Chen and McKnight, 2007) has been extended to implicate the
circadian machinery in the DNA-damage response (Collis
and Boulton, 2007). The circadian genes per1 and tim have
been shown to play an important role in DNA-damage control
(Gery et al., 2006; Unsal-Kac¸maz et al., 2005), and phase reset-
ting of the mammalian circadian clock is readily obtained by
DNA-damaging agents (Oklejewicz et al., 2008). Finally, the
role of SIRT1 in the aging process (Oberdoerffer and Sinclair,
2007; Bishop and Guarente, 2007) is intriguingly paralleled by re-
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observed in BMAL1-deficient mice (Kondratov et al., 2006). The
far-reaching implications of our findings are thereby multiple, in-
cluding the identification of novel strategies for the study of dia-
betes, obesity, and aging.
EXPERIMENTAL PROCEDURES
Animals
Male BALB/c mice and liver-specific Sirt1/ mice were housed under 12 hr
light/12 hr dark (LD) cycles over 2 weeks. All protocols using animals were
approved by the Institutional Animal Care andUse Committee of the University
of California, Irvine.
Plasmids
FLAG-tagged and Myc-tagged plasmids have been described (Doi et al.,
2006; Travnickova-Bendova et al., 2002). Full and truncated mouse Clock
ORFs were amplified by PCR and cloned in pG4MpolyII vector. Mouse
Clock(D19) was amplified by PCR from c/cMEFs. Mouse SIRT1 ORF was sub-
cloned into pcDNA3with a FLAG epitope sequence at the 50 end. hSIRT1-Flag/
pcDNA3.1, hSIRT2-Flag /pcDNA3.1, and hSIRT3-Flag /pcDNA3.1 were kind
gifts of E. Verdin. Flag-hSIRT1/pECE, Flag-hSIRT1(H363Y)/pECE, hSIRT1-
HA/pECE, and hSIRT1(H363Y)-HA/pECE were kind gifts of A. Brunet.
Antibodies
Antibodies against acetyl-histone H3, histone H4, and SIRT1 were from Milli-
pore, antibodies against CLOCK and rabbit IgG from Santa Cruz Biotechnol-
ogy, and antibodies against Flag (M2) and b-actin from Sigma. Antibodies
against BMAL1 and Myc were described (Cardone et al., 2005). Polyclonal
acetyl-lysine 537 BMAL1antibody was generated by immunizing rabbits with
KLH-conjugates of the peptide NH2-ASSPGG[acetyl-K]KILN- (mouse BMAL1).
Cell Culture
MEFs were generated from WT or homozygous Sirt1/ sibling mice and cul-
tured in DMEM (4.5 g/l glucose) supplemented with 7.5% newborn bovine
serum, 2.5% FBS, and antibiotics. JEG3 cells were grown in Basal Medium
Eagle supplemented with 10% FBS and antibiotics.
Preparation of Cell Extracts and Nuclear Extracts
from Cultured Cell Lines
Cells were washed twice with phosphate-buffered saline (PBS) and lysed in
RIPA buffer (50 mM Tris/HCL [pH 8.0], 150 mM NaCl, 5 mM EDTA, 15 mM
MgCl2, 1% NP40, 13 protease inhibitor cocktail [Roche], 1 mM DTT, 1 mM
trichostatin A [TSA], 10 mM NAM, 10 mM NaF, 1 mM PMSF). For nuclear
extracts (Andrews and Faller, 1991), after washing cells with cold PBS, cells
were lysed with hypotonic buffer (10 mM HEPES-KOH [pH 7.9], 1.5 mM
MgCl2, 10 mM KCl, 13 protease inhibitor cocktail [Roche], 1 mM DTT, 1 mM
TSA, 10 mM NAM, 10 mM NaF, 1 mM PMSF). Following a brief centrifugation,
pellet was resuspended in hypertonic buffer (20 mM HEPES-KOH [pH 7.9],
25% glycerol, 420 mMNaCl 1.5 mMMgCl2, 0.2 mM EDTA, 13 protease inhib-
itor cocktail [Roche], 1 mM DTT, 1 mM TSA, 10 mM NAM, 10 mM NaF, 1 mM
PMSF). Supernatants were recovered as nuclear extracts.
ChIP Assays
Conventional ChIP assay was used for histones from MEFs (Yamamoto et al.,
2004). For nonhistone proteins, dual crosslinking ChIP assay (Nowak et al.,
2005) was used with slight modifications. After serum shock, cells were
washed three times with room temperature PBS, then PBS/1 mM MgCl2
was added. Disuccinimidyl Glutalate (DSG) was added to a final concentration
of 2 mM for crosslinking. After 45 min at room temperature, formaldehyde was
added to a final concentration of 1%(v/v) and cells incubated for 15 min. After
dual crosslinking, glycine was added to a final concentration of 0.1 M and
incubated for 10 min to quench formaldehyde out. After harvesting, cells
were lysed in 500 ml ice-cold cell lysis buffer (50 mM Tris/HCl [pH 8.0],
85 mM KCl, 0.5% NP40, 1 mM PMSF, 13 protease inhibitor cocktail [Roche])
for 10 min on ice. Nuclei were precipitated by centrifugation (3000 g for 5 min),
resuspended in 600 ml ice-cold RIPA buffer (50 mM Tris/HCl [pH 8.0], 150 mM338 Cell 134, 329–340, July 25, 2008 ª2008 Elsevier Inc.NaCl, 1 mM EDTA [pH 8.0], 1% Triton X-100, 0.1% SDS, 0.1% sodium deox-
ycholate, 1 mM PMSF, 13 protease inhibitor cocktail [Roche]), and incubated
on ice for 30min. Sonication was done to obtain DNA fragments 100–600 bp in
length.
Quantitative Real-Time RT-PCR
Each quantitative real-time RT-PCR was performed using the Chromo4 real
time detection system (BIO-RAD). The PCR primers for mDbp mRNA, mPer2
mRNA, mCry1 mRNA, 18S rRNA, Dbp UP, Dbp E-box, Dbp 30R, and mSIRT1
mRNA were described (Ripperger and Schibler, 2006; Rodgers et al., 2005;
Yamamoto et al., 2004). PCR primers for Dbp TSS were designed using
Real-Time PCR Primer Design (https://www.genscript.com/ssl-bin/app/
primer), and the sequences are available upon request. For a 20 ml PCR,
50 ng of cDNA template was mixed with the primers to final concentrations
of 200 nM and 10 ml of iQ SYBR Green Supermix (BIO-RAD), respectively.
The reaction was first incubated at 95C for 3 min, followed by 40 cycles at
95C for 30 s and 60C for 1 min.
RNase Protection Assays
RNA extractions were done using TRIzol (GIBCO BRL). RNase protection as-
says (RPAs) were performed as described (Pando et al., 2002). The riboprobes
were generated using an in vitro transcription kit (Promega). Data were quan-
tified using a phosphorimager.
Recombinant Proteins, [35S] Labeling, and GST Pulldown Assay
GST-fused recombinant proteins were expressed in E. coli BL21. Recombi-
nant proteins were lysed by CelLytic B Cell Lysis Reagent (Sigma) according
to the manufacturer’s protocol and purified by glutathione Sepharose 4B
(Amersham). 35S-methionine-labeled proteins were made in vitro using the
TNT-T7 quick-coupled transcription-translation system (Promega). Twenty
microliters of in vitro-translated 35S-methionine-labeled proteins and 1 mg of
GST-mSIRT1 or GST on glutathione Sepharose were added in a 1 ml binding
buffer (50 mM Tris/HCl [pH 8.0], 150 mM NaCl, 1% NP-40), incubated over-
night at 4C. After washing sepharose with binding buffer three times, proteins
were analyzed on SDS-PAGE.
SIRT1 Deacetylation Assay
SIRT1 deacetylase activity was determined using a SIRT1 Fluorimetric Activity
Assay/Drug Discovery Kit (AK-555; BIOMOL International) following the man-
ufacturer’s protocol. Extracts from serum-stimulated MEFs and liver from
entrained mice lysed by RIPA buffer were used for measuring SIRT1 deacety-
lase activity. Complementation assays were performed by adding recombi-
nant E. coli-generated SIRT1, and they included 1 U/reaction of SIRT1 protein
and 25 mM of substrate (acetylated p53) in a 50 ml final volume. Endogenous
SIRT1 from liver was obtained by immunoprecipitation and then incubated in
deacetylase buffer with the substrate and 0.1 mM NAD+ for 1 hr at 37C.
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
at http://www.cell.com/cgi/content/full/134/2/329/DC1/.
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